最新发布
L’Oréal clears Innovist deal, moving in on India’s digital beauty boom
The Competition Commission of India (CCI) has approved L’Oréal India’s acquisition of Onesto Labs, the parent company of beauty house Innovist. The clearance confirms that the deal, which was first announced in June, is on track to close in the coming months.
AgriFood Signals: Confido raises $55m to help CPGs, Tesco backs Henry Dimbleby’s fund, UPF food labeling
AgFunderNews rounds up the most important fundings, mergers, acquisitions, closures, and industry buzz in agtech and foo…
FDA keeps Newron’s evenamide trial on hold in U.S.
Why it matters: The decision comes shortly after the Italian biotech said it expected U.S. enrollment in ENIGMA-TRS 2 to resume “in the near future.” Newron is testing evenamide as an add-on treatment for people with treatment-resistant schizophrenia.
Sound Agriculture launches seed-applied biological to preserve yields on high ammonium corn acres
Ammonia and manure are two of the most effective ways to give corn the nitrogen it needs, but they come with a cost to t…
甘肃省瓜州县农机中心开展2026年第五批农机购置与应用补贴现场核验
为全面落实国家、省、市农机购置与应用补贴各项政策要求,进一步规范补贴实施全流程,守牢惠农资金安全关口,把农机惠民政策实实在在送到农户手中,近期,甘肃省瓜州县农机中心组织业务骨干下沉基层一线,赴锁阳城镇、双塔镇等乡镇开展第五批农机购置与应…
Addex regains rights to addiction drug candidate from Indivior
Why it matters: Addex gets back the candidate and related intellectual property without paying Indivior. “There were no payments or financial considerations on the return and no obligations on either side,” an Addex spokesperson told European Biotechnology.
🎥Agrifood VC needs a different playbook, says Pymwymic: “Corporate venture capital needs to step in earlier”
In agrifoodtech investing, says Pymwymic managing partner Rogier Pieterse, it might be time to stop shooting for the sta…
Novo licenses Nanexa’s long-acting injection platform in €1.165B deal
Why it matters: The new collaboration targets monthly and quarterly injections. If that longer dosing interval works in patients, it could give Novo another way to distinguish its weekly obesity and diabetes treatments, such as Wegovy and Ozempic, in diseases where treatment convenience is becoming a growing competitive advantage.
Bavarian Nordic names new CEO; Abivax and ProQR add key leaders
Bavarian Nordic: Tarja Stenvall to become CEO. The Danish vaccine maker has chosen the former Sanofi executive to succeed Paul Chaplin on Oct. 15. Stenvall brings commercial and vaccine experience to a company that grew under Chaplin from a research-focused biotech into a global vaccine supplier. Go deeper.
Roche signs two deals worth about $3.5B in one day
Atavistik: Roche will pay the Cambridge, Massachusetts, biotech $70 million (€62 million) upfront, with up to $1.9 billion (€1.67 billion) in research, development and commercial milestones, plus royalties. Atavistik will use its AMPS platform to find binding pockets on proteins and design small molecules against several disease targets. Roche will take over further preclinical development, clinical trials and commercialization.
